Welcome to our dedicated page for Curaleaf Hldgs news (Ticker: CURLF), a resource for investors and traders seeking the latest updates and insights on Curaleaf Hldgs stock.
Curaleaf Holdings, Inc. (OTCQX: CURLF, TSX: CURA) generates frequent news as an international provider of consumer cannabis products operating across medical and adult-use markets. Company updates often highlight its portfolio of brands, including Curaleaf, Select, Grassroots, Find, Anthem and The Hemp Company, and how these brands are deployed through retail dispensaries and international channels.
News coverage for Curaleaf commonly includes corporate and regulatory developments, such as its announced intention to seek shareholder approval for a proposed arrangement to continue from British Columbia, Canada to Delaware in the United States. This proposed domestication is described by the company as a way to align its corporate structure with its operational focus while maintaining its listings on the Toronto Stock Exchange and OTCQX.
Investors and observers can also expect retail expansion and operational updates. Recent announcements have covered the opening and relocation of dispensaries, including Curaleaf Millcreek in Erie, Pennsylvania, and Curaleaf Cape Canaveral in Florida. These releases describe new store locations, in-store experience, and the availability of products such as premium flower, vapes and edibles under the company’s brands.
Curaleaf’s news flow further includes transaction and financing announcements, such as its binding commitment to acquire, and later the termination of that commitment for, The Cannabist Company’s Virginia assets, and the upsizing of its revolving credit facility with Needham Bank from $40 million to $100 million. In addition, the company issues financial results releases, including quarterly reports prepared under U.S. GAAP that detail segment revenue, margins, cash flow and non-GAAP performance measures.
Beyond financial and operational items, Curaleaf also reports on community and social initiatives like its Feed the Block fundraiser to address food insecurity and partnerships with organizations such as the Baldwin Fund. For those tracking CURLF, this news page brings together these various categories of updates in one place.
Curaleaf Holdings has successfully completed the acquisition of Deseret Wellness, the largest cannabis retail operator in Utah, enhancing its strategic position in the state. The cash and stock transaction, valued at approximately US$20 million, adds three retail dispensaries in Park City, Provo, and Payson to Curaleaf's existing footprint, bringing its total to four in Utah and 150 nationwide. This acquisition aligns with Curaleaf's goal to expand its presence in emerging markets, capitalizing on Utah's rapidly growing medical cannabis program that generated US$118.7 million in sales last year. The newly acquired dispensaries are projected to generate an annualized revenue run rate of US$14 million, positioning Curaleaf for long-term growth.
Curaleaf Holdings, a leading cannabis provider, has announced a definitive agreement to acquire Deseret Wellness, Utah's largest cannabis retail operator, for approximately US$20 million. This acquisition is expected to enhance Curaleaf's retail presence in Utah, expanding its footprint to four dispensaries in the state and 150 nationwide. Deseret Wellness, which operates three dispensaries in Park City, Provo, and Payson, has an annualized revenue run rate of US$14 million. The deal represents a significant change of ownership in Utah's cannabis market and aims to improve access to high-quality cannabis products for medical patients.
Curaleaf Holdings, Inc. (CURLF) has launched JAMS, a new cannabis edibles brand, in Florida, with an upcoming release in Arizona and plans to expand to more states. JAMS offers a variety of products, including jellies, fast-acting jellies, chocos, and tarts, designed for both new and experienced cannabis consumers. Each product is crafted with innovative delivery technologies, ensuring consistency and efficacy. The edibles market is growing, and JAMS aims to satisfy the increasing consumer demand for flavorful and reliable cannabis products. Curaleaf operates in 19 states with 147 dispensaries, employing nearly 5,500 team members across the U.S.
Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) announced a delay in its fourth quarter and full year earnings release, initially set for March 28, 2023. The company requires additional time to transition three years of financials from IFRS to U.S. GAAP and review various accounting matters. Curaleaf expects to file its financial statements by April, adhering to the required securities laws deadlines. Operating in 19 states with 147 dispensaries and nearly 5,500 employees, Curaleaf aims to provide clarity and confidence in cannabis consumption.
Curaleaf Holdings announced the expansion of its partnership with B NOBLE, a Black-owned cannabis brand, into Florida. Products will be available at Curaleaf's 58 dispensaries statewide. Founded by Fab 5 Freddy, B NOBLE focuses on social equity and aims to support job opportunities through GreenBook Academy, donating 10% of sales to this cause. B NOBLE will launch with products like Lady Madonna and PB Souffle strains. Curaleaf's CEO, Matt Darin, emphasized Florida's growing market, while GreenBook Academy's founder, Noemi Perez, highlighted the importance of inclusivity in the cannabis industry. Curaleaf operates in 19 states with nearly 5,500 employees.
Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) will announce its fourth quarter and fiscal year 2022 financial results on March 28, 2023, before market open. The company plans to conduct a conference call at 8:30 a.m. ET for discussing operational and financial highlights, followed by a Q&A session. Curaleaf operates 147 dispensaries across 19 states in the U.S. and is a leader in the cannabis industry, focusing on consumer product clarity and confidence.
Curaleaf Holdings, operating in Connecticut, has initiated adult-use cannabis sales at its Hartford dispensary starting March 1, 2023. This marks the first adult-use dispensary in Hartford and follows similar sales launched in Stamford earlier this year. Curaleaf aims to enhance consumer experience by providing diverse product offerings and a revamped loyalty rewards program. Existing medical patients will benefit from priority access and dedicated services. The company plans to expand its adult-use services further, pending regulatory approvals, reinforcing its commitment to serving both medical and adult-use markets in Connecticut.
Summary not available.
Curaleaf Holdings, Inc. (CSE: CURA; OTCQX: CURLF) announces the opening of its first dispensary in Stamford, Connecticut, which will begin adult-use cannabis sales on January 28, 2023, at 10:00 a.m. This new location expands Curaleaf's footprint in Connecticut, where it already serves medical patients at three other dispensaries. To celebrate the launch, the Stamford dispensary will host festivities including product discounts and giveaways. The company aims to maintain quality care for its medical patients while welcoming adult-use consumers. Curaleaf operates in 19 states, with 147 dispensaries and nearly 5,500 employees, positioning itself strongly in the cannabis market.
Curaleaf Holdings (CURLF) is streamlining operations by closing most facilities in California, Colorado, and Oregon, aiming to enhance cash flow and profitability. The company anticipates a 10% workforce reduction, targeting gross run-rate savings of $60 million, surpassing initial goals. Despite these states contributing less than $50 million in revenue last year, Curaleaf believes these measures will boost adjusted EBITDA margins and free cash flow, projected to exceed $125 million in 2023. CEO Matt Darin emphasizes the need for improved margins and cash generation in core markets, stating these strategic moves are essential for the company's future success.